Effects of a hydroxylated metabolite of the β-adrenoreceptor antagonist, carvedilol, on post-ischaemic splanchnic tissue injury

被引:15
作者
Christopher, TA
Lopez, BL
Ma, XL
Feuerstein, GZ
Ruffolo, RR
Yue, TL
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Div Emergency Med, Philadelphia, PA 19107 USA
[2] SmithKline Beecham Pharmaceut, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA
关键词
endothelium; leukocytes; reactive oxygen species; antioxidant;
D O I
10.1038/sj.bjp.0701598
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Reactive oxygen species have been demonstrated to play a critical role in post-ischaemic tissue injury. The present experiment was designed to evaluate the effects of SE 211475, a hydroxylated metabolite of the new beta-adrenoceptor antagonist, carvedilol, on rat splanchnic ischaemia (SI. 60 min) and reperfusion(R)-induced shock and tissue injury. 2 Administration of SE 211475 two min before R attenuated SI/R injury in a dose-dependent manner. At doses of 0.5 mg kg(-1) and 1.0 mg kg(-1), SE 211475 exerted significant anti-shock and endothelial protective effects, characterized by prolonged survival times, increased survival rates, attenuated increases in tissue myeloperoxidase activity and haematocrits, and preserved endothelium-dependent vasorelaxation. 3 Administration of 1 mg kg(-1) carvedilol attenuated shock-induced tissue injury and endothelial dysfunction. However, administration of 0.5 mg kg(-1) carvedilol had no protective effects on postischaemic tissue injury. 4 Previous studies have shown that SE 211475 has virtually no beta-blocking activity but possesses more potent antioxidant activity than carvedilol. In the present study, SE 211475 exerted more potent protective effects than the parent compound, suggesting that this metabolite of carvedilol is superior to carvedilol with regard to its protection against post-ischaemia tissue injury.
引用
收藏
页码:292 / 298
页数:7
相关论文
共 24 条
[1]  
BECKMAN JS, 1994, ANN NY ACAD SCI, V738, P69
[2]   OXYGEN-DERIVED FREE-RADICALS AND MYOCARDIAL REPERFUSION INJURY - AN OVERVIEW [J].
BOLLI, R .
CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 :249-268
[3]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[4]   Endotoxin-induced oxidative stress in the rat small intestine: Role of nitric oxide [J].
Chamulitrat, W ;
Skrepnik, NV ;
Spitzer, JJ .
SHOCK, 1996, 5 (03) :217-222
[5]  
CHRISTOPHER TA, 1995, J PHARMACOL EXP THER, V273, P64
[6]   Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection [J].
Feuerstein, GZ ;
Ruffolo, RR .
EUROPEAN HEART JOURNAL, 1996, 17 :24-29
[7]   MOLECULAR MECHANISMS INVOLVED IN SUPEROXIDE-INDUCED LEUKOCYTE-ENDOTHELIAL CELL-INTERACTIONS IN-VIVO [J].
GABOURY, JP ;
ANDERSON, DC ;
KUBES, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (02) :H637-H642
[8]   ROLE OF LYSOSOMES IN PATHOGENESIS OF SPLANCHNIC ISCHEMIA SHOCK IN CATS [J].
GLENN, TM ;
LEFER, AM .
CIRCULATION RESEARCH, 1970, 27 (05) :783-&
[9]  
GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47
[10]  
GRANGER DN, 1981, GASTROENTEROLOGY, V81, P22